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DistributionCatechol-O-methyltransferase (COMT) inactivates the catecholamines adrenaline, noradrenaline and dopa-
mine. On the other hand, some studies have reported that the enzymatic activity of COMT is partly genetically
determined. With regard to the COMT gene, the most studied polymorphism is the functional variant Val108/
158Met (rs4680), which results in substantial three- to four-fold variations in enzyme activity. To date, the
rs4680 polymorphism of COMT has been associated with a number of disorders. In addition, this polymor-
phism has been found to have important differences in frequency according to the studied population.
Therefore, the aim of the present study was to evaluate the frequency of a common single nucleotide poly-
morphism (SNP) Val108/158Met of the COMT gene in the Mexican population. Accordingly, we recruited
431 healthy volunteers. Our sample consisted of 111 healthy individuals from Mexico City and 320 individ-
uals from the state of Tabasco, Mexico. We observed that Met was the most common allele, ranging from
57% (Tabasco) to 85% (Mexico City). In addition, we analyzed the frequency of Val108/158Met polymorphism
of Caucasian (54% Met allele), Asian (29% Met allele) and African (34% Met allele) populations separately
and also in comparison with Mexican (63% Met allele) population. In conclusion, the distribution of the
Val108/158Met polymorphism distinguishes the Mexican population studied from other populations, but it
is necessary to increase the size of the sample to get more conclusive results.
© 2013 The Authors. Published by Elsevier B.V. All rights reserved.1. Introduction
Catechol-O-methyl-transferase (COMT) is a major catabolic regu-
lator of synaptic catecholamine neurotransmitters; this enzyme cata-
lyzes the transfer of a methyl group to catecholamines and degrades
dopamine, norepinephrine and epinephrine (Pivac et al., 2011).
COMT is densely expressed throughout both the prefrontal cortex
(PFC) and limbic system (Schosser et al., 2012). The enzyme activityase; SNP, single nucleotide
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some band 22q11.2 (Wardle et al., 2013).
Most COMT genetic association studies have focused on a particu-
lar single nucleotide polymorphism (SNP), the Val108/158Met poly-
morphism. This entails a common G to A transition in exon 4 of the
COMT gene, producing a valine (Val) to methionine (Met) substitu-
tion at amino acid position 108 or 158 (Lee and Kim, 2011). The
Met allele in this polymorphism is associated with a three- or
four-fold decrease in COMT activity, whereas the Val allele is identi-
ﬁed with its highest activity (Lachman et al., 1996). The COMT gene
is transcribed from two promoters to produce a cytoplasmic form
(soluble; S-COMT, transcribed form P1) and a membrane-bound
form (MB-COMT, transcribed form P2) (Baud et al., 2007). S-COMT
is the short version of the enzyme characterized by a change in an
amino acid at position 108 (Val108Met), whereas MB-COMT is the
long form which includes a change in an amino acid at position 158
(Val158Met) (Nedic et al., 2011).
The Val108/158Met polymorphism of the COMT gene has been ex-
tensively tested in meta-analysis, case–control and family-based as-
sociation studies for its possible participation in several diseasesserved.
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chotic and affective disorders, as well as in other situations such as
smoking, cognitive processing and post-menopausal breast cancer
risk (Baud et al., 2007; Calati et al., 2011; Cheng et al., 2006; Colilla
et al., 2005; Ehrlich et al., 2010; Illi et al., 2010; Kia-Keating et al.,
2007; Kocabas et al., 2010; Lee and Kim, 2011; Liou et al., 2001;
Martínez-Ramírez et al., 2012; Nedic et al., 2011; Nikolac et al.,
2013; Nolan et al., 2000; Ohara et al., 1998; Ono et al., 2004;
Opgen-Rhein et al., 2008; Perroud et al., 2010; Pivac et al., 2011;
Roten et al., 2011; Russ et al., 2000; Takizawa et al., 2009;
Vargas-Alarcón et al., 2007; Wedren et al., 2003; Zalsman et al.,
2008). The important single nucleotide polymorphism has been ge-
notyped in most of the populations worldwide. However, the COMT
gene has been analyzed in several association studies with inconclu-
sive results. One of the possible explanations for the discrepancies
in the outcomes may be that the distribution of the frequency of the
COMT gene varies according to the populations (Hatzimanolis et al.,
2013; Sheikh et al., 2013; Wardle et al., 2013). In consequence, the
distribution of the genotype and allele frequencies of the COMT
gene in a certain population is a relevant issue. Therefore, as one of
our samples we chose the population of Tabasco, Mexico, which is a
closed population. The aim of this study was to investigate the distri-
bution of allele and genotype frequencies of the Val108/158 polymor-
phism in Mexico City and in the state of Tabasco and to compare our
ﬁndings with other populations.
2. Material and methods
2.1. Subjects
In order to evaluate the genotype and allele frequency of the poly-
morphism Val108/158Met in the Mexican population we included a
sample consisting of 111 healthy individuals recruited from the
Carracci Medical Group in Mexico City and 320 subjects randomly
recruited when they attended the Blood Donor Center in the munici-
pality of Comalcalco in the state of Tabasco, Mexico. Part of the sam-
ple of the Tabasco population was taken from previous reports
(Tovilla-Zárate et al., 2011, 2013). We included a total of 431 healthy
volunteers in the present study; all the participants were Mexican
Mestizos, and to reduce ethnic variation and stratiﬁcation effects,
we selected subjects that descended from two Mexican generations.
The exclusion criteria for both populations (Mexico City and Tabasco)
were the following: current substance abuse, history of substance de-
pendence, history of neurobiological disease, intellectual disability or
other concomitant medical ailment.
2.2. Description of the populations
2.2.1. Population A or Tabasco population
Tabasco is one of the 31 states comprising the 32 federal entities
which constitute Mexico. It is located in the southeast of the country
along the Gulf of Mexico. It has as boundaries the states of Campeche,
Chiapas and Veracruz, as well as the country of Guatemala. The
Tabasco population is considered to have been originated from late
Mesoamerican cultures. The state of Tabasco is divided into 17 munic-
ipalities, but our subjects came solely from the one called Comalcalco
(Fig. 1). Only subjects of Mestizo Mexican descent were included in
this study.
2.2.2. Population B or Mexico City population
Mexico City is the capital of Mexico. It is a federal entity that to-
gether with the 31 Mexican states conform a federation. The growth
of the city has extended beyond its limits and has inﬁltrated 59 mu-
nicipalities in the state of Mexico and 1 in the state of Hidalgo. Al-
though we included only Mexican individuals descending from
Mexican parents and grandparents, this population is less closedthan the one of Tabasco (Fig. 1). Only subjects of Mexican Mestizo de-
scent were included in this study.
2.3. Ethics statement
After they were given a verbal and written explanation of the re-
search objectives, all subjects signed an informed consent to participate
in the study. They did not receive any economical remuneration. This
study compliedwith the principles convened in theHelsinki Declaration.
In addition, this study was approved by the ethics committee so-called
DAMC-UJAT Ethics and Research Committee (UJAT-DAMC-2012-02) of
the University of Tabasco.
2.4. Genotype assays
Genomic DNA was extracted from peripheral blood leukocytes
using a modiﬁed version of the protocol by Lahiri (Lahiri and
Nurnberger, 1991). The genotypes of the COMT Val108/158Met poly-
morphism were analyzed in all subjects using a polymerase chain re-
action (PCR) end-point method. The ﬁnal volume of the PCR reaction
was 5 μL and consisted of 20 ng genomic DNA, 2.5 FL TaqMan Master
Mix, and 0.125 FL 20× Assay. The ampliﬁcation was performed in
96-well plates using the TaqMan Universal Thermal Cycling Protocol.
After the PCR end-point was reached, ﬂuorescence intensity was
measured with the 7500 Real-Time PCR system using SDS version
2.1 software (Applied Biosystems). An allelic discrimination was
performed resulting in the clear identiﬁcation of three genotypes for
the COMT Val108/158Met polymorphism. All genotyping was carried
out blind to patient outcome. As a quality control in our genotyping
analyses we used random blind duplicates. Genotype assays were
previously reported elsewhere (Tovilla-Zárate et al., 2011).
2.5. Statistical analysis
We measured frequencies and percentages of the genotypes and
alleles using the SPSS statistical program version 11.5. Similarly, we
used the THESIAS software v. 3.1. Chi-square statistics were used for
testing goodness of ﬁt to the Hardy–Weinberg equilibrium.
3. Results
The distribution of genotype and allele frequencies of the Val108/
158Met polymorphism in the Mexican population of our study is
shown in Table 1. The frequencies of these studies in the Mexican
population were in Hardy–Weinberg equilibrium. Table 2 shows the
genotype and allele frequencies in Caucasian, African and Asian pop-
ulations that were studied in relation to the Val108/158Met polymor-
phism. Likewise, all these frequencies were in Hardy–Weinberg
equilibrium.
4. Discussion
The aim of the present study was to estimate allele and genotype
frequencies of the Val108/158Met polymorphism in a Mexican popu-
lation. The Met allele in this polymorphism is associated with a three-
to four-fold decrease in COMT activity, whereas the Val allele is relat-
ed to its highest activity. Data from several studies have established
that the Val108/158 Met polymorphism plays an important role in
many diseases such as schizophrenia, alcohol dependence, suicidal
behavior, psychotic and affective disorders, as well as in studies
concerning smoking, cognitive processing and post-menopausal
breast cancer risk. Hence, it is relevant to study the Val108/158Met
polymorphism in different populations.
Table 1 shows genotype and allele frequencies observed in the
two populations. Met was the most common allele ranging from
57% (Tabasco) to 85% (Mexico City). We compared the analysis with
Fig. 1. Map of Mexico showing the reported genotype frequency of the Val108/158Met polymorphism in different population groups.
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2013 (Martínez-Ramírez et al., 2012; Vargas-Alarcón et al., 2007; both
having women samples). In the study by Martínez-Ramírez et al.Table 1
Allele and genotype frequencies of the Val108/158Met polymorphism in different sam-
ples of the Mexican population.
Genotype Frequency p Allele Frequency p HWE
Tabasco (Tovilla-Zárate)
Met-Met n (%) 106 (0.33) b0.0001 Met n (%) 367 (0.57) b0.0001 0.90
Met-Val n (%) 155 (0.48) Val n (%) 273 (0.43)
Val-Val n (%) 59 (0.19)
Total 320 Total 640
Mexico City (Tovilla-Zárate)
Met-Met n (%) 79 (0.71) b0.0001 Met n (%) 189 (0.85) b0.0001 0.45
Met-Val n (%) 31(0.28) Val n (%) 33 (0.15)
Val-Val n (%) 1 (0.01)
Total 111 Total 222
Mexico City (Martínez-Ramírez)
Met-Met n (%) 68 (0.45) 0.60 Met n (%) 195 (0.65) 0.39 0.10
Met-Val n (%) 59 (0.39) Val n (%) 105 (0.35)
Val-Val n (%) 23 (0.16)
Total 150 Total 300
Mexico City (Vargas-Alarcón)
Met-Met n (%) 4(0.12) 0.81 Met n (%) 22 (0.33) b0.0001 0.79
Met-Val n (%) 14(0.42) Val n (%) 44 (0.67)
Val-Val n (%) 15(0.46)
Total 33 Total 66
Overall Mexican population
Met-Met n (%) 257 (0.42) Met n (%) 773 (0.63) 0.01*
Met-Val n (%) 259 (0.42) Val n (%) 455 (0.37)
Val-Val n (%) 98 (0.16)
Total 614 Total 1228
The p value was calculated when we compared each population vs pool of frequencies
of the rest of Mexican population.
Example: Tabasco population (Tovilla-Zarate) vs Mexico city (Tovilla-zarate)+Mexico
city (Martínez-Ramírez)+Mexico city (Vargas-Alarcón).(2012) the more frequent allele was Met by 65% and the Val allele
exhibited a lower frequency (35%). This study included individuals
from all over Mexico. With regard to the study of Vargas-Alarcón et
al. (2007), the frequencies for the Val and Met alleles were 67% and
33%, respectively. Our results are in agreement with the study by
Martínez-Ramírez et al. (2012) which reported a higher frequency for
the Met allele (65%) than for the Val allele (35%). Conversely, when we
compared our results with Vargas-Alarcón et al. (2007), they reported
that the allele with higher frequency was Val (67%). One possible expla-
nation could be the difference in genetic heterogeneity in the popula-
tions even though both belonged to the same country. Vargas-Alarcón
et al. (2007) included in their study individuals from different states of
Mexico, whereas our sample was more homogeneous.
Allele and genotype frequencies of these polymorphisms inMexican
individuals were compared to those reported in other populations —
Caucasian, Asian, andAfrican.We performed an analysis of the genotype
andallele frequencies of the Val108/158Met polymorphismwith studies
comprising healthy individuals as controls. The pooled results of Cauca-
sian populations showed that theMet allele had a frequency of 54% and
Val allele frequency of 46%; the Asian population exhibited a frequency
of 29% for the Met allele and 71% for the Val allele, and the African pop-
ulation presented a frequency of 34% for the Met allele and 67% for the
Val allele. These control subjects were recruited from different ethnics
and populations (Table 2). We obtained similar results for theMet allele
frequency between the pooled results of the various control groups and
the Tabasco population, but we observed a minor discrepancy with the
Mexico City sample. Our results contradict the allele frequencies when
compared to the studies in Asian and African populations and the
study by Vargas-Alarcón et al. (2007). The possible explanation for this
discrepancy could be the sample size. Our sample size for both Tabasco
and Mexico City populations was larger when compared to the other
studies in Mexican subjects mentioned above.
Among the limitations of our study lies the fact that the subjects
were not randomly recruited to be a representative sample of a spe-
ciﬁc ethnic group. Besides, we did not calculate the sample size. Final-
ly, we did not present an association report.
Table 2
Comparison of allele and genotype frequencies in Caucasian, Asian and African populations.
Study Population Number of controls Genotype frequency Allele frequency
Met-Met n (%) Met-Val n (%) Val-Val n (%) p Met n (%) Val n (%) P HWE
Ehrlich 2010 Caucasians 114 28 (0.25) 56 (0.49) 30 (0.26) 112 (0.49) 116 (0.51)
Roten 2011 Caucasians 2187 678 (0.31) 1097 (0.50) 412 (0.19) 2453(0.56) 1921(0.44)
Kocabas 2010 Caucasians 291 83 (0.28) 140 (0.48) 68 (0.24) 306 (0.53) 276 (0.47)
Wedrén 2003 Caucasians 1340 433 (0.32) 662 (0.49) 245 (0.19) 1528(0.57) 1152(0.43)
Illi 2010 Caucasians 395 106 (0.27) 205 (0.52) 84 (0.21) 417 (0.53) 373 (0.47)
Opgen 2008 Caucasians 40 6 (0.15) 21 (0.53) 13 (0.32) 47 (0.59) 33 (0.41)
Pivac 2011 Caucasians 198 45 (0.23) 97 (0.49) 56 (0.28) 187 (0.47) 209 (0.53)
Colilla 2005 Caucasians 543 127 (0.23) 291 (0.54) 125 (0.23) 545 (0.50) 541 (0.50)
Nikolac 2013 Caucasians 771 186 (0.24) 401 (0.52) 184 (0.24) 773 (0.50) 769 (0.50)
Total 5879 1692 (0.28) 2970 (0.51) 1217 (0.21) b0.0001 6368(0.54) 5390(0.46) b0.0001 0.00*
Takizawa 2009 Asians 60 5 (0.08) 25 (0.42) 30 (0.50) 35 (0.29) 85 (0.71)
Total 60 5 (0.08) 25 (0.42) 30 (0.50) b0.0001 35 (0.29) 85 (0.71) b0.0001 0.94
Colilla 2005 Africans 242 26 (0.11) 114 (0.47) 102 (0.42) 166 (0.34) 318 (0.67)
Total 242 26 (0.11) 114 (0.47) 102 (0.42) b0.0001 166 (0.34) 318 (0.67) b0.0001 0.56
Overall population
Total 6181 1723 (0.28) 3109 (0.50) 1349 (0.22) 6569 (0.53) 5793 (0.47) 0.00*
The p value was calculated when we compared each population vs pool of frequencies of overall Mexican population.
457T.B. González-Castro et al. / Gene 526 (2013) 454–458In summary, the distribution of the Val108/158Met polymorphism
distinguishes the Mexican population studied from other groups
including Caucasians, Africans and Asians. The alleles of Val108/158Met
are associated with the development of different diseases; hence the
knowledge of the distribution of these alleles could be important for
the understanding of its genetic role in a speciﬁc population.
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